BRAF mutations in metastatic colorectal cancer (mCRC) can present unique challenges in treatment and patient care, but also can be targets for therapy. This symposium aims to enhance participants' abilities to tailor molecular-guided treatment for patients with BRAF V600E-mutated mCRC. Expert speakers will provide practical insights for optimizing patient care, supported by the latest evidence from both clinical trials and real-world studies. The panel will cover best practices for biomarker testing, and will explore different therapeutic strategies, focusing on personalizing treatment approaches for optimal outcomes. This live event will also highlight the importance of multidisciplinary collaboration in delivering comprehensive, patient-centered care, ultimately improving the management and quality of life for patients with BRAF V600E-mutated mCRC.
This symposium will be offered in person or virtually. If you are planning to attend in person, you must be a registered attendee of ESMO Gastrointestinal Cancers Congress 2025 in order to participate.
MODERATOR / COURSE DIRECTOR
Julien Taieb, MD, PhD
Université Paris Cité (Descartes)
Hôpital Européen Georges-Pompidou
Paris, France
PANELIST
Chiara Cremolini, MD, PhD
Professor of Medical Oncology
University of Pisa
Pisa, Italy
PANELIST
Mar Iglesias, MD
Associate Professor
Universitat Pompeu Fabra
Head
Pathology Department
Hospital del Mar
Barcelona, Spain
PATIENT ADVOCATE
Laure Chotel
Digestive Cancers Europe
France
12:45 TZ
12:50 TZ
13:05 TZ
13:15 TZ
13:40 TZ
Plaça de Willy Brandt, 11-14, 08019 Barcelona, Spain
Have increased knowledge regarding the
Have greater competence related to
Demonstrate greater confidence in their ability to
This programme is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) for 1.0 hours of external CE credit(s). Each participant should claim only those hours of credit that have actually been spent in the educational activity.
Total effective education time: 60 minutes. EBAC Activity ID #: 2025-EPN-6722000-000
Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals and the American Medical Association, physicians may convert EBAC® CE credits/points to AMA PRA Category 1 CreditsTM. Information on the process to convert EBAC® credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 CreditTM.